AAAAAA

   
Results: 1-8 |
Results: 8
IMPACT OF RENAL DYSFUNCTION ON METABOLITES OF NITRIC-OXIDE (NO) IN RENAL-ALLOGRAFT RECIPIENTS
Authors: DAI FX WINKLHOFER F COWLEY B CHONKO A PIERCE G GREATHOUSE J LAYES D SKOPEC J DIEDERICH A DIEDERICH D
Citation: Fx. Dai et al., IMPACT OF RENAL DYSFUNCTION ON METABOLITES OF NITRIC-OXIDE (NO) IN RENAL-ALLOGRAFT RECIPIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3053-3053
MYCOPHENOLATE SUPPRESSES NITRIC-OXIDE (NO) PRODUCTION DURING ANTILYMPHOCYTE THERAPY IN RENAL-ALLOGRAFT RECIPIENTS
Authors: WINKLHOFER F DAI FX COWLEY B CHONKO A PIERCE G GREATHOUSE J LAYES D SKOPEC J DIEDERICH A DIEDERICH D
Citation: F. Winklhofer et al., MYCOPHENOLATE SUPPRESSES NITRIC-OXIDE (NO) PRODUCTION DURING ANTILYMPHOCYTE THERAPY IN RENAL-ALLOGRAFT RECIPIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3287-3287
SERUM PERMEABILITY ACTIVITY PREDICTS OUTCOME OF THERAPY TO PREVENT ALLOGRAFT LOSS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Authors: BHADURI S FLORENCE L ARTERO M ROSS K BRENNAN D WINKLHOFER F MCCARTHY E SHARMA R ABRAMS J DIEDERICH D LEWIS R STROM T VINCENTI F SAVIN V
Citation: S. Bhaduri et al., SERUM PERMEABILITY ACTIVITY PREDICTS OUTCOME OF THERAPY TO PREVENT ALLOGRAFT LOSS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), Journal of the American Society of Nephrology, 8, 1997, pp. 3301-3301
RENAL-FUNCTION AND METABOLITES OF NITRIC-OXIDE (NO) IN BLOOD - NITROSOPROTEINS, NITRITE AND NITRATE
Authors: DIEDERICH D DAI FX WINKLHOFER F SKOPEC J DIEDERICH A
Citation: D. Diederich et al., RENAL-FUNCTION AND METABOLITES OF NITRIC-OXIDE (NO) IN BLOOD - NITROSOPROTEINS, NITRITE AND NITRATE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1553-1553
CIRCULATING NITROSOPROTEINS INCREASE DURING OKT3 THERAPY IN HUMAN RENAL-ALLOGRAFT RECIPIENTS
Authors: WINKLHOFER F DAI FX SKOPEC J DIEDERICH A GREATHOUSE J LAYES D PIERCE G DIEDERICH D
Citation: F. Winklhofer et al., CIRCULATING NITROSOPROTEINS INCREASE DURING OKT3 THERAPY IN HUMAN RENAL-ALLOGRAFT RECIPIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1631-1631
RAMIPRIL-MEDIATED REDUCTIONS IN DIABETIC RENAL HYPERTROPHY AND URINARY ALBUMIN EXCRETION RATE OCCUR INDEPENDENT OF BLOOD-PRESSURE CHANGES
Authors: WINKLHOFER F MARPLE J CHONKO M COWLEY B WIEGMANN T
Citation: F. Winklhofer et al., RAMIPRIL-MEDIATED REDUCTIONS IN DIABETIC RENAL HYPERTROPHY AND URINARY ALBUMIN EXCRETION RATE OCCUR INDEPENDENT OF BLOOD-PRESSURE CHANGES, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1052-1052
FELODIPINE PREVENTS DEVELOPMENT OF DIABETIC NEPHROPATHY IN THE STZ-DIABETIC RAT
Authors: WINKLHOFER F CHONKO M COWLEY B WIEGMANN T
Citation: F. Winklhofer et al., FELODIPINE PREVENTS DEVELOPMENT OF DIABETIC NEPHROPATHY IN THE STZ-DIABETIC RAT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1052-1052
NITRIC-OXIDE PRODUCTION RENAL-ALLOGRAFT RECIPIENTS - EFFECTS OF ACUTEREJECTION AND CYCLOSPORINE (CSA)
Authors: WINKLHOFER F DAL FX SKOPEC J DIEDERICH A GREATHOUSE J LAYES D PIERCE G DIEDERICH D
Citation: F. Winklhofer et al., NITRIC-OXIDE PRODUCTION RENAL-ALLOGRAFT RECIPIENTS - EFFECTS OF ACUTEREJECTION AND CYCLOSPORINE (CSA), Journal of the American Society of Nephrology, 6(3), 1995, pp. 1122-1122
Risultati: 1-8 |